RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Drug Reaction with Eosinophilia and Systemic Symptoms: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Probable Olanzapine-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
Pramod Dattawadkar P et al., Journal of clinical psychopharmacology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42877995/
- 2.
Subacute Infective Endocarditis Complicated by Vancomycin-Induced DRESS Syndrome and Large Intracerebral Hemorrhage.
Cui Yaling et al., JACC. Case reports (6 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42841829/
- 3.
115 TNF-α Blockade for Carbamazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Min Zou et al., Journal of Investigative Dermatology (1 October 2026)
https://doi.org/10.1016/j.jid.2026.09.140
- 4.
Anti-seizure medications and DRESS in paediatric patients: A FAERS disproportionality and time-to-onset analysis.
Yang Ting et al., British journal of clinical pharmacology (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42397303/
- 5.
Early use of mepolizumab in DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome: A prospective multicenter, open-label, pilot study.
Yun James et al., Journal of the American Academy of Dermatology (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42822774/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Drug Reaction with Eosinophilia and Systemic Symptoms
Drug reaction with eosinophilia and systemic symptoms is a rare but serious reaction to a medicine. It usually appears two to eight weeks after starting the drug and causes a widespread rash, fever, swollen glands and a high eosinophil count. It can also inflame organs such as the liver, kidneys and lungs. Treatment involves stopping the medicine that caused it, supportive care and often corticosteroids.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Drug Reaction with Eosinophilia and Systemic Symptoms?
Drug reaction with eosinophilia and systemic symptoms is a rare but serious reaction to a medicine. It usually appears two to eight weeks after starting the drug and causes a widespread rash, fever, swollen glands and a high eosinophil count. It can also inflame organs such as the liver, kidneys and lungs. Treatment involves stopping the medicine that caused it, supportive care and often corticosteroids.
How many clinical trials are available for Drug Reaction with Eosinophilia and Systemic Symptoms?
RareWays currently indexes 3 clinical trials for Drug Reaction with Eosinophilia and Systemic Symptoms. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Drug Reaction with Eosinophilia and Systemic Symptoms come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Drug Reaction with Eosinophilia and Systemic Symptoms.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.